Adapthealth Corp
NASDAQ:AHCO
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Adapthealth Corp
Cash & Cash Equivalents
Adapthealth Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adapthealth Corp
NASDAQ:AHCO
|
Cash & Cash Equivalents
$79.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
158%
|
CAGR 10-Years
N/A
|
|
Cardinal Health Inc
NYSE:CAH
|
Cash & Cash Equivalents
$3.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Cash & Cash Equivalents
$159m
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
2%
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Cash & Cash Equivalents
$124m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-12%
|
|
Mckesson Corp
NYSE:MCK
|
Cash & Cash Equivalents
$4.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
1%
|
|
Cencora Inc
NYSE:COR
|
Cash & Cash Equivalents
$2.1B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
11%
|
See Also
What is Adapthealth Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
79.6m
USD
Based on the financial report for Mar 31, 2024, Adapthealth Corp's Cash & Cash Equivalents amounts to 79.6m USD.
What is Adapthealth Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
158%
Over the last year, the Cash & Cash Equivalents growth was -22%. The average annual Cash & Cash Equivalents growth rates for Adapthealth Corp have been -16% over the past three years , 158% over the past five years .